Global Market Study on Induced Pluripotent Stem Cell

May 2018| PMR863A| Persistence Market Research

Report Highlights

Overview of the iPS Cell Market with Reference to the Global Healthcare Sector Outlook

Despite the economic and political uncertainty in the recent past, the global healthcare industry has been receiving positive nudges from reformative and technological disruptions in medical devices, pharmaceuticals and biotech, in-vitro diagnostics, and medical imaging. Key markets across the world are facing a massive rise in demand for critical care services that are pushing global healthcare spending levels to unimaginable limits.

A rapidly multiplying geriatric population; increasing prevalence of chronic ailments such as cancer and cardiac disease; growing awareness among patients; and heavy investments in clinical innovation are just some of the factors that are impacting the performance of the global healthcare industry. Proactive measures such as healthcare cost containment, primary care delivery, innovation in medical procedures (3-D printing, blockchain, and robotic surgery to name a few), safe and effective drug delivery, and well-defined healthcare regulatory compliance models are targeted at placing the sector on a high growth trajectory across key regional markets.

Parent Indicators Healthcare

Current expenditure on health, % of gross domestic product
Current expenditure on health, per capita, US$ purchasing power parities (current prices, current PPPs)
Annual growth rate of current expenditure on health, per capita, in real terms
Out-of-pocket expenditure, % of current expenditure on health
Out-of-pocket expenditure, per capita, US$ purchasing power parity (current prices, current PPPs)
Physicians, Density per 1000 population (head counts)
Nurses, Density per 1000 population (head counts)
Total hospital beds, per 1000 population
Curative (acute) care beds, per 1000 population
Medical technology, Magnetic Resonance Imaging units, total, per million population
Medical technology, Computed Tomography scanners, total, per million population

Research Methodology

PMR utilizes a triangulation methodology that is primarily based on overall expenditure on life science research and R&D funding and capital equipment installed base to obtain precise market estimations and insights on life science and biotechnology associated products, technologies, applications and services. Bottom-up approach is always used to obtain insightful data for the specific country/regions. The country-specific data is again analysed to derive data at a global level. This methodology ensures high quality and accuracy of information.

Secondary research is used at the initial phase to identify the feasibility of the target products/technology categories and its respective segments, product and service offerings, equipment installed base in end use facilities, adoption rate and future impact of new technologies. Additionally, per capita consumption of kits, reagents and consumables among end users is tracked at a granular level to obtain the most accurate information. Each piece of information is eventually analysed during the entire research project which builds a strong base for the primary research information.

Primary research participants include demand-side respondents such as laboratory managers, procurement managers, research supervisors at academic and research institutes, as well as key opinion leaders in addition to supply-side respondents such as equipment and reagent manufacturers, custom solution and service providers who provide valuable insights on trends, research application of products and technologies, purchasing patterns, services offered and associated pricing.

Quantitative and qualitative assessment of basic factors driving demand, economic factors/cycles and growth rates and strategies utilized by key players in the market is analysed in detail while forecasting, in order to project year-on-year growth rates. These Y-o-Y growth projections are checked and aligned as per associated industry/product lifecycles and further utilized to develop market numbers at a holistic level.

On the other hand, we also analyse annual reports of various companies, investor presentations, SEC filings, 10k reports and earning call transcripts operating in the market to fetch substantial information about the market size, trends, opportunity, drivers, restraints and to analyse key players and their market shares. Key companies are segmented at tier-level based on their revenues, product portfolio and presence.

Please note that these are the partial steps that are being followed while developing the market size. Besides this, forecasting will be done based on our internal proprietary model which also uses different macro-economic factors such as overall life science research expenditure, R&D funding, industry based demand driving factors impacting the market and its forecast trends apart from other macroeconomic factors.

Standard Report Structure

Executive Summary
Market Definition
Macro-economic analysis
Parent Market Analysis
Market Overview
Forecast Factors
Segmental Analysis and Forecast
Regional Analysis
Competition Analysis
Market Taxonomy

The global iPS cell market has been segmented into:

Cell Type

Hepatocytes
Fibroblasts
Keratinocytes
Neurons
Others
Application

Drug Development
Regenerative Medicine
Toxicity Testing
End User

Academic and Research Institutes
Biotechnology Companies
Region

North America
Latin America
Europe
Asia Pacific excluding China (APEC)
China
Middle East and Africa (MEA)

  • Table 1 : Comparison of Stem Cell Types
  • Table 2 : Expenditure on Health, (% of GDP), by Country, 2016 - 2021
  • Table 3 : Expenditure on Health, (% of GDP), by Country, 2016 - 2021
  • Table 4 : Induced Pluripotent Stem Cells (iPSCs) Clinical Trials
  • Table 5 : Induced Pluripotent Stem Cells (iPSCs) Clinical Trials
  • Table 6 : Induced Pluripotent Stem Cells (iPSCs) Clinical Trials
  • Table 7 : Induced Pluripotent Stem Cells (iPSCs) Clinical Trials
  • Table 8 : Induced Pluripotent Stem Cells (iPSCs) Clinical Trials
  • Table 9 : Induced Pluripotent Stem Cells (iPSCs) Clinical Trials
  • Table 10 : Induced Pluripotent Stem Cells (iPSCs) Clinical Trials
  • Table 11 : North America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
  • Table 12 : North America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Cell Type
  • Table 13 : North America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Application Type
  • Table 14 : North America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User
  • Table 15 : North America Induced Pluripotent Stem Cell Market Company Intensity Map
  • Table 16 : Economic support and stem cell research for the major countries in Latin America, (2013)
  • Table 17 : Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
  • Table 18 : Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Cell Type
  • Table 19 : Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Application Type
  • Table 20 : Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User
  • Table 21 : Latin America Induced Pluripotent Stem Cell Market Company Intensity Map
  • Table 22 : Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
  • Table 23 : Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Cell Type
  • Table 24 : Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Application Type
  • Table 25 : Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User
  • Table 26 : Europe Induced Pluripotent Stem Cell Market Company Intensity Map
  • Table 27 : Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
  • Table 28 : Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Cell Type
  • Table 29 : Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Application Type
  • Table 30 : Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User
  • Table 31 : Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Company Intensity Map
  • Table 32 : China Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Cell Type
  • Table 33 : China Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Application Type
  • Table 34 : China Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User
  • Table 35 : China Induced Pluripotent Stem Cell Market Company Intensity Map
  • Table 36 : Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
  • Table 37 : Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Cell Type
  • Table 38 : Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Application Type
  • Table 39 : Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User
  • Table 40 : Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Company Intensity Map
  • Table 41 : Global Induced Pluripotent Stem Cell Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Region
  • Table 42 : Global Induced Pluripotent Stem Cell Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Cell Type
  • Table 43 : Global Induced Pluripotent Stem Cell Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Application Type
  • Table 44 : Global Induced Pluripotent Stem Cell Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User
  • Figure 1 : All R&D expenditure, by Source of Fund, 2011
  • Figure 2 : R&D expenditure in Life Science, by R&D Field, 2011
  • Figure 3 : Leading cause of Death, 2014
  • Figure 4 : Global Stem Cell Market Overview (2016E)
  • Figure 5 : Main Obstacles in Stem Cell Research
  • Figure 6 : Number of Companies (estimated) Offering iPSC Research products, by Year
  • Figure 7 : Global Healthcare Expenditure in US$ Tn (2013-2020)
  • Figure 8 : The Number of Estimated Active Researchers in Stem Cell Research Worldwide
  • Figure 9 : North America Induced Pluripotent Stem Cell Market Value Share (2017A), By Country
  • Figure 10 : North America Induced Pluripotent Stem Cell Market Value Share (2017A), By Cell Type, Application and End User
  • Figure 11 : iPSC Specific U.S. Patents, by patent type, 2015
  • Figure 12 : National contribution to iPSC invention, by country, 2014
  • Figure 13 : Total number of patents for iPSC technologies (Est.)
  • Figure 14 : North America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 15 : North America Induced Pluripotent Stem Cell Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
  • Figure 16 : North America Induced Pluripotent Stem Cell Market Y-o-Y growth (%) Comparison, By Country, 2018-2026
  • Figure 17 : U.S. Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 18 : U.S. Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 19 : Canada Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 20 : Canada Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 21 : North America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017, By Hepatocytes
  • Figure 22 : North America Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026, By Hepatocytes
  • Figure 23 : North America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017, By Fibroblasts
  • Figure 24 : North America Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026, By Fibroblasts
  • Figure 25 : North America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017, By Keratinocytes
  • Figure 26 : North America Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026, By Keratinocytes
  • Figure 27 : North America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017, By Neurons
  • Figure 28 : North America Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026, By Neurons
  • Figure 29 : North America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017, By Others
  • Figure 30 : North America Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026, By Others
  • Figure 31 : North America Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Cell Type
  • Figure 32 : North America Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Application Type
  • Figure 33 : North America Induced Pluripotent Stem Cell Market Attractiveness Analysis, By End User
  • Figure 34 : North America Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Country
  • Figure 35 : Latin America Induced Pluripotent Stem Cell Market Value Share (2017A), By Country
  • Figure 36 : Latin America Induced Pluripotent Stem Cell Market Value Share (2017A), By Cell Type, Application and End User
  • Figure 37 : Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 38 : Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
  • Figure 39 : Latin America Induced Pluripotent Stem Cell Market Y-o-Y growth (%) Comparison, By Country, 2018-2026
  • Figure 40 : Brazil Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 41 : Brazil Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 42 : Mexico Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 43 : Mexico Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 44 : Argentina Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017, By Country
  • Figure 45 : Argentina Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 46 : Rest of Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017, By Country
  • Figure 47 : Rest of Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 48 : Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017, By Hepatocytes
  • Figure 49 : Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026, By Hepatocytes
  • Figure 50 : Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017, By Fibroblasts
  • Figure 51 : Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026, By Fibroblasts
  • Figure 52 : Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017, By Keratinocytes
  • Figure 53 : Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026, By Keratinocytes
  • Figure 54 : Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017, By Neurons
  • Figure 55 : Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026, By Neurons
  • Figure 56 : Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017, By Others
  • Figure 57 : Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026, By Others
  • Figure 58 : Latin America Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Cell Type
  • Figure 59 : Latin America Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Application Type
  • Figure 60 : Latin America Induced Pluripotent Stem Cell Market Attractiveness Analysis, By End User
  • Figure 61 : Latin America Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Country
  • Figure 62 : Europe Induced Pluripotent Stem Cell Market Value Share (2017A), By Country
  • Figure 63 : Europe Induced Pluripotent Stem Cell Market Value Share (2017A), By Cell Type, Application and End User
  • Figure 64 : Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 65 : Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
  • Figure 66 : Europe Induced Pluripotent Stem Cell Market Y-o-Y growth (%) Comparison, By Country, 2018-2026
  • Figure 67 : Germany Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017, By Country
  • Figure 68 : Germany Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 69 : U.K. Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017, By Country
  • Figure 70 : U.K. Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 71 : France Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017, By Country
  • Figure 72 : France Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 73 : Italy Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017, By Country
  • Figure 74 : Italy Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 75 : Spain Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017, By Country
  • Figure 76 : Spain Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 77 : Russia Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017, By Country
  • Figure 78 : Russia Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 79 : Rest of Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017, By Country
  • Figure 80 : Rest of Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 81 : Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017, By Hepatocytes
  • Figure 82 : Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026, By Hepatocytes
  • Figure 83 : Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017, By Fibroblasts
  • Figure 84 : Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026, By Fibroblasts
  • Figure 85 : Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017, By Keratinocytes
  • Figure 86 : Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026, By Keratinocytes
  • Figure 87 : Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017, By Neurons
  • Figure 88 : Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026, By Neurons
  • Figure 89 : Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017, By Others
  • Figure 90 : Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026, By Others
  • Figure 91 : Europe Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Cell Type
  • Figure 92 : Europe Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Application Type
  • Figure 93 : Europe Induced Pluripotent Stem Cell Market Attractiveness Analysis, By End User
  • Figure 94 : Europe Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Country
  • Figure 95 : Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Value Share (2017A), By Country
  • Figure 96 : Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Value Share (2017A), By Cell Type, Application and End User
  • Figure 97 : Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 98 : Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
  • Figure 99 : APEC Induced Pluripotent Stem Cell Market Y-o-Y growth (%) Comparison, By Country, 2018-2026
  • Figure 100 : Japan Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 101 : Japan Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 102 : India Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 103 : India Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 104 : Australia and New Zealand Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 105 : Australia and New Zealand Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 106 : Rest of APEC Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 107 : Rest of APEC Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 108 : APEC Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017, By Hepatocytes
  • Figure 109 : APEC Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026, By Hepatocytes
  • Figure 110 : APEC Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017, By Fibroblasts
  • Figure 111 : APEC Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026, By Fibroblasts
  • Figure 112 : APEC Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017, By Keratinocytes
  • Figure 113 : APEC Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026, By Keratinocytes
  • Figure 114 : APEC Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017, By Neurons
  • Figure 115 : APEC Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026, By Neurons
  • Figure 116 : Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017, By Others
  • Figure 117 : Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026, By Others
  • Figure 118 : Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Cell Type
  • Figure 119 : Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Application Type
  • Figure 120 : Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Attractiveness Analysis, By End User
  • Figure 121 : Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Country
  • Figure 122 : China Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 123 : China Induced Pluripotent Stem Cell Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
  • Figure 124 : China Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017, By Hepatocytes
  • Figure 125 : China Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026, By Hepatocytes
  • Figure 126 : China Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017, By Fibroblasts
  • Figure 127 : China Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026, By Fibroblasts
  • Figure 128 : China Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017, By Keratinocytes
  • Figure 129 : China Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026, By Keratinocytes
  • Figure 130 : China Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017, By Neurons
  • Figure 131 : China Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026, By Neurons
  • Figure 132 : China Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017, By Others
  • Figure 133 : China Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026, By Others
  • Figure 134 : China Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Cell Type
  • Figure 135 : China Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Application Type
  • Figure 136 : China Induced Pluripotent Stem Cell Market Attractiveness Analysis, By End User
  • Figure 137 : Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Value Share (2017A), By Country
  • Figure 138 : Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Value Share (2017A), By Cell Type, Application and End User
  • Figure 139 : Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 140 : Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
  • Figure 141 : MEA Induced Pluripotent Stem Cell Market Y-o-Y growth (%) Comparison, By Country, 2018-2026
  • Figure 142 : GCC Countries Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 143 : GCC Countries Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 144 : South Africa Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 145 : South Africa Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 146 : Rest of MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 147 : Rest of MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 148 : MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017, By Hepatocytes
  • Figure 149 : MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026, By Hepatocytes
  • Figure 150 : MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017, By Fibroblasts
  • Figure 151 : MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026, By Fibroblasts
  • Figure 152 : MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017, By Keratinocytes
  • Figure 153 : MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026, By Keratinocytes
  • Figure 154 : MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017, By Neurons
  • Figure 155 : MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026, By Neurons
  • Figure 156 : MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017, By Others
  • Figure 157 : MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026, By Others
  • Figure 158 : Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Cell Type
  • Figure 159 : Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Application Type
  • Figure 160 : Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Attractiveness Analysis, By End User
  • Figure 161 : Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Country
  • Figure 162 : Revenue Contribution by Tier Type (2016)
  • Figure 163 : Global Induced Pluripotent Stem Cell Market Share (%) Analysis
  • Figure 164 : Global Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Region
  • Figure 165 : Global Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Cell Type
  • Figure 166 : Global Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Application Type
  • Figure 167 : Global Induced Pluripotent Stem Cell Market Attractiveness Analysis, By End User
  • Figure 168 : Global Induced Pluripotent Stem Cell Market Size and Y-o-Y, 2013 - 2017
  • Figure 169 : Global Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 170 : Global Induced Pluripotent Stem Cell Market Absolute $ Opportunity, 2017-2026

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organization of all sizes.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report